Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Clinical trial NCT06484530 · UNKNOWN

Trial details

NCT number: NCT06484530
Sponsor: Mahidol University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Tuberculosis (TB)Isoniazid Toxicity Rifampicin Toxicity Pyrazinamide Adverse Reaction Ethambutol Toxicity NAT2 Slow Acetylator Status NAT2 Rapid Acetylator Status NAT2 Polymorphism N-Acetylcysteine

Start date: 2024-03-12
Primary completion: 2024-09-18
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.